Clinical Diagnostics

Clinical Diagnostics Market Research Reports & Consulting

MarketsandMarkets focuses on dynamic segments such as clinical diagnostics that are going through continuous development with emergence of new technologies. Under this segment MarketsandMarkets provides research on markets that include molecular diagnostics, reagent market, services market, invitro diagnostics (IVD), clinical laboratory instrumentation, Point-of-Care and other markets.

Market Reports

Title	Published	Price
In-Vitro Diagnostic (IVD) Market (Applications, End-users & Types) Trends & Global Forecasts (Major & Emerging Markets – G7, Japan & BRIC) (2011 - 2016) The Asian region is expected to be ruled by the emerging economies such as China and India, show the highest CAGR by the year 2016. The Chinese IVD market is taking frog leap amongst the emerging nations, followed by India, Russia, and Brazil. The major driving factor for the IVD industry to boom in the emerging countries is the government funding and improved healthcare facilities.	January 2012	$ 4650
Global Clinical Trials Market (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework) This research report categorizes the Global Clinical Trials Market on the basis of phases, indications, and study design analyzing trends in each. Each section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide more than 20 company profiles.	September 2011	$ 4650
Global Nuclear Medicine (Medical Isotopes/ Radioisotopes/ Radiopharmaceuticals) Market in PET/SPECT Imaging and Therapy - Competitive Landscape, Current trends and Forecasts (2010 – 2015) Radiopharmaceuticals are pharmaceutical agents used to diagnose certain medical problems such as cardiac, cancer, neurology, and/or treat certain conditions such as cancers. The use of radiopharmaceuticals as tracer dates back to 1930’s. Over the years, technical advancement in production, diagnostic equipments (SPECT and PET), and discovery of new radiopharmaceutical have driven the market. The global radiopharmaceutical market for therapy and PET & SPECT imaging was valued at $3,213 million in 2010 and is expected to reach $4,734 million by 2015; growing at a CAGR of 8.1% from 2010 to 2015. The PET & SPECT diagnosis accounted for the largest share -90%- of the global radiopharmaceutical market.	August 2011	$ 4650
Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010-2015 Supportive national health policies and increased healthcare spending by emerging economies are expected to boost the market for diagnostic imaging equipments in Brazil, Russia, India and China. In addition, the technological advancements such as portable ultrasound systems will further boost the market growth in emerging markets. Heavy import duties are restraining the growth of diagnostic imaging equipments. However, leading players such as GE Healthcare and Philips Healthcare are entering into partnerships with local manufacturers for the manufacture of diagnostic imaging equipments at lower cost. Computed tomography systems are found to be a high growth segment followed by Ultrasound systems and magnetic resonance imaging. This report “Emerging Markets (BRIC- Brazil, Russia, India, China): Diagnostic Imaging” covers all the major diagnostic imaging equipments such as magnetic resonance imaging, ultrasound systems, computed tomography systems, mammography equipments, X-ray systems and nuclear imaging systems in four of the major emerging economies such as Brail, Russia, India and China.	September 2010	$ 4650
Patient Monitoring Devices - Emerging Markets BRIC(Brazil, Russia, India, China) 2010-2015 The Emerging Markets: BRIC (Brazil, Russia, India and China) Patient Monitors witnesses significant growth opportunities due to rapidly aging population, high incidence of chronic diseases, and government initiatives such as reform in healthcare delivery systems. Despite the impact of economic slowdown, BRIC nations are expected to grow at a CAGR of around 10 - 12% from 2009 – 2014.	July 2010	$ 4650
US Neonatal (Preterm) Infant Care Market (2010-2015) Preterm infant care forms a significant part of the pediatric healthcare market in U.S as preterm births are on a alarming rise in the nation. Preterm births are one of the leading causes of infant mortality in U.S with 1 in 8 births being preterm. Induced fertility and labor treatments, poor prenatal care, inappropriate maternal age, obesity, smoking are some of the major reasons responsible for increasing incidence of preterm births in the country. Preterm infant care products such as infant care devices, infant formula and drugs face a great demand in United States due to the absolute necessity of such products in sustaining baby lives. The products are indispensable in saving preterm babies because they are biologically immature and require external medical assistance in the form of respiratory, nutritional and thermal control support for survival. Infant care products have helped to increase the survival of preterm babies in the country. The criticality of the products in preterm infant care is driving the market. Furthermore, technology advances in regards to multi function equipments are also propelling the growth of the market.	June 2010	$ 4650
Autoimmune Treatment Market (2009 - 2014) The report sizes the market for the diagnosis and therapeutic technologies for the auto immune diseases. It also tracks the advances in the technologies along with the profiles and strategies of the key players in this market. The report highlights the new approaches being pursued in this market.	September 2009	$ 4650
Global Human Immunodeficiency Virus (HIV) Market (2010 – 2015) Human immunodeficiency virus (HIV) is a retrovirus which causes Acquired Immunodeficiency syndrome (AIDS) in humans, a condition where immune system fails, leading to opportunistic infections that is life threatening. HIV infection occurs via transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk and major routes of infection transmission are unsafe sex, contaminated needles, perinatal transmission, breast milk and infected blood products.	March 2012	$ 4650